{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:50:08Z","timestamp":1763988608393,"version":"3.44.0"},"reference-count":51,"publisher":"Becaris Publishing Limited","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Comp. Eff. Res."],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>\n            <jats:bold>Aim:<\/jats:bold>\n            To compare healthcare resource utilization (HCRU) and costs between older adults with and without acromegaly.\n            <jats:bold>Materials &amp; methods:<\/jats:bold>\n            Using 2017\u20132022 100% Medicare Research Identifiable Files, we identified beneficiaries (\u226565\u00a0years) with prevalent cases of acromegaly. A randomly selected claim with an acromegaly diagnosis was the index date. Beneficiaries were required to have continuous enrollment in Medicare fee-for-service and Part D for the 1-year post-index period (observation period). Beneficiaries with acromegaly were matched 1:1 (age, sex, race, US geographic region) to acromegaly-free beneficiaries (reference group). The beneficiaries in the reference group were assigned the same index date as their matched beneficiary with acromegaly and met the same enrollment criteria. Outcomes of interest, measured during the observation period, included all-cause and acromegaly-related HCRU and costs (adjusted to 2022 US dollars).\n            <jats:bold>Results:<\/jats:bold>\n            We identified 3491 beneficiaries with acromegaly and 3491 without acromegaly. The mean age was 73.1\u00a0years and the majority of beneficiaries were female and non-Hispanic White. Beneficiaries with acromegaly had more HCRU than those without acromegaly, including a greater proportion with hospitalizations (27.6 vs 14.9%), ED visits (31.8 vs 22.8%), use of skilled nursing facility care (7.3 vs 3.5%) and home health agency visits (18.1 vs 8.4%) (p\u00a0&lt;\u00a00.001 for all). Total all-cause healthcare costs were higher among beneficiaries with acromegaly versus those without acromegaly ($45,830 vs $18,922, p\u00a0&lt;\u00a00.001). The majority of beneficiaries with acromegaly (69.6%) did not have evidence of acromegaly treatment.\n            <jats:bold>Conclusion:<\/jats:bold>\n            Medicare beneficiaries with acromegaly have substantial HCRU and costs compared with controls without acromegaly; this indicates a high burden of illness which may be lessened by new and effective therapeutic options for those with acromegaly.\n          <\/jats:p>","DOI":"10.57264\/cer-2025-0076","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T10:39:04Z","timestamp":1751971144000},"source":"Crossref","is-referenced-by-count":1,"title":["Clinical and economic burden among older adults with acromegaly in the United States"],"prefix":"10.57264","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4861-4285","authenticated-orcid":false,"given":"Tiffany P","family":"Quock","sequence":"first","affiliation":[{"name":"Crinetics Pharmaceuticals, San Diego, CA 92121, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0177-6153","authenticated-orcid":false,"given":"Eunice","family":"Chang","sequence":"additional","affiliation":[{"name":"ADVI Health, LLC, Washington, DC 20004, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7110-9463","authenticated-orcid":false,"given":"Ashis K","family":"Das","sequence":"additional","affiliation":[{"name":"ADVI Health, LLC, Washington, DC 20004, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8789-1384","authenticated-orcid":false,"given":"Amanda","family":"Speller","sequence":"additional","affiliation":[{"name":"ADVI Health, LLC, Washington, DC 20004, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0818-5113","authenticated-orcid":false,"given":"Marian H","family":"Tarbox","sequence":"additional","affiliation":[{"name":"ADVI Health, LLC, Washington, DC 20004, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3567-0862","authenticated-orcid":false,"given":"Stacy K","family":"Rattana","sequence":"additional","affiliation":[{"name":"Crinetics Pharmaceuticals, San Diego, CA 92121, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3591-7293","authenticated-orcid":false,"given":"Ingrid E","family":"Paulson","sequence":"additional","affiliation":[{"name":"Crinetics Pharmaceuticals, San Diego, CA 92121, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2049-5536","authenticated-orcid":false,"given":"Michael S","family":"Broder","sequence":"additional","affiliation":[{"name":"ADVI Health, LLC, Washington, DC 20004, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"36897","reference":[{"key":"e_1_3_7_3_2","unstructured":"Orphanet. Acromegaly (2024). Available at: https:\/\/www.orpha.net\/en\/disease\/detail\/963"},{"issue":"2","key":"e_1_3_7_4_2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.mayocp.2021.11.007","article-title":"Diagnosis and treatment of acromegaly: an update","volume":"97","author":"Ershadinia N","year":"2022","unstructured":"Ershadinia N, Tritos NA. Diagnosis and treatment of acromegaly: an update. Mayo Clin. Proc. 97(2), 333\u2013346 (2022).","journal-title":"Mayo Clin. Proc."},{"key":"e_1_3_7_5_2","volume-title":"StatPearls","author":"Adigun OO","year":"2024","unstructured":"Adigun OO, Nguyen M, Fox TJ, Anastasopoulou C. Acromegaly. In: StatPearls. StatPearls Publishing, FL, USA (2024)."},{"issue":"1","key":"e_1_3_7_6_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1750-1172-3-17","article-title":"Acromegaly","volume":"3","author":"Chanson P","year":"2008","unstructured":"Chanson P, Salenave S. Acromegaly. Orphanet J. Rare Dis. 3(1), 17 (2008).","journal-title":"Orphanet J. Rare Dis."},{"issue":"5","key":"e_1_3_7_7_2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.beem.2009.05.010","article-title":"Acromegaly","volume":"23","author":"Chanson P","year":"2009","unstructured":"Chanson P, Salenave S, Kamenicky P, Cazabat L, Young J. Acromegaly. Best Pract. Res. Clin. Endocrinol. Metab. 23(5), 555\u2013574 (2009).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"24","key":"e_1_3_7_8_2","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Acromegaly","volume":"355","author":"Melmed S","year":"2006","unstructured":"Melmed S. Acromegaly. N. Engl. J. Med. 355(24), 2558\u20132573 (2006).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"e_1_3_7_9_2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1530\/EJE-20-0019","article-title":"Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality","volume":"182","author":"Esposito D","year":"2020","unstructured":"Esposito D, Ragnarsson O, Johannsson G, Olsson DS. Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality. Eur. J. Endocrinol. 182(6), 523\u2013531 (2020).","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"e_1_3_7_10_2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11102-012-0447-z","article-title":"Diagnostic delay is associated with psychosocial impairment in acromegaly","volume":"16","author":"Siegel S","year":"2013","unstructured":"Siegel S, Streetz-van der Werf C, Schott JS, Nolte K, Karges W, Kreitschmann-Andermahr I. Diagnostic delay is associated with psychosocial impairment in acromegaly. Pituitary 16(4), 507\u2013514 (2013).","journal-title":"Pituitary"},{"key":"e_1_3_7_11_2","doi-asserted-by":"crossref","first-page":"704496","DOI":"10.3389\/fendo.2021.704496","article-title":"Patient-identified problems and influences associated with diagnostic delay of acromegaly: a nationwide cross-sectional study","volume":"12","author":"Wang K","year":"2021","unstructured":"Wang K, Guo X, Yu S Patient-identified problems and influences associated with diagnostic delay of acromegaly: a nationwide cross-sectional study. Front. Endocrinol. 12, 704496 (2021).","journal-title":"Front. Endocrinol."},{"key":"e_1_3_7_12_2","first-page":"P426","article-title":"Acromegaly in the elderly: additional challenges in timely recognizing","volume":"90","author":"Pekic DS","year":"2023","unstructured":"Pekic DS, Stojanovic M, Doknic M Acromegaly in the elderly: additional challenges in timely recognizing. Endocr. Abstr. 90, P426 (2023).","journal-title":"Endocr. Abstr."},{"issue":"4","key":"e_1_3_7_13_2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40618-024-02519-8","article-title":"Diagnostic delay, older age, and hormonal levels at diagnosis affect disease burden and mortality in acromegaly","volume":"48","author":"Gasco V","year":"2024","unstructured":"Gasco V, Prencipe N, Cuboni D Diagnostic delay, older age, and hormonal levels at diagnosis affect disease burden and mortality in acromegaly. J. Endocrinol. Invest. 48(4), 919\u2013929 (2024).","journal-title":"J. Endocrinol. Invest."},{"issue":"6","key":"e_1_3_7_14_2","doi-asserted-by":"crossref","first-page":"638","DOI":"10.20945\/2359-3997000000194","article-title":"Acromegaly in the elderly patient","volume":"63","author":"Jallad RS","year":"2020","unstructured":"Jallad RS, Bronstein MD. Acromegaly in the elderly patient. Arch. Endocrinol. Metab. 63(6), 638\u2013645 (2020).","journal-title":"Arch. Endocrinol. Metab."},{"issue":"3","key":"e_1_3_7_15_2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1530\/EJE-19-0794","article-title":"All-cause mortality in patients with acromegaly treated with pegvisomant: an ACROSTUDY analysis","volume":"182","author":"Tritos NA","year":"2020","unstructured":"Tritos NA, Mattsson AF, Vila G All-cause mortality in patients with acromegaly treated with pegvisomant: an ACROSTUDY analysis. Eur. J. Endocrinol. 182(3), 285\u2013292 (2020).","journal-title":"Eur. J. Endocrinol."},{"key":"e_1_3_7_16_2","doi-asserted-by":"crossref","first-page":"1348972","DOI":"10.3389\/fendo.2024.1348972","article-title":"High mortality risk among women with acromegaly still persists","volume":"15","author":"G\u0103loiu S","year":"2024","unstructured":"G\u0103loiu S, Toma I-D, T\u0103nasie DI High mortality risk among women with acromegaly still persists. Front. Endocrinol. 15, 1348972 (2024).","journal-title":"Front. Endocrinol."},{"issue":"1","key":"e_1_3_7_17_2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1186\/s12877-021-02549-4","article-title":"Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study","volume":"21","author":"Gagliardi I","year":"2021","unstructured":"Gagliardi I, Chiloiro S, Vallillo M Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study. BMC Geriatr. 21(1), 598 (2021).","journal-title":"BMC Geriatr."},{"key":"e_1_3_7_18_2","doi-asserted-by":"crossref","first-page":"819330","DOI":"10.3389\/fendo.2022.819330","article-title":"The effect of aging on quality of life in acromegaly patients under treatment","volume":"13","author":"Yamamoto N","year":"2022","unstructured":"Yamamoto N, Urai S, Fukuoka H The effect of aging on quality of life in acromegaly patients under treatment. Front. Endocrinol. 13, 819330 (2022).","journal-title":"Front. Endocrinol."},{"issue":"1","key":"e_1_3_7_19_2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s42000-020-00235-5","article-title":"Clinical presentation and management of acromegaly in elderly patients","volume":"20","author":"Ceccato F","year":"2021","unstructured":"Ceccato F, Barbot M, Lizzul L Clinical presentation and management of acromegaly in elderly patients. Horm. Athens Greece 20(1), 143\u2013150 (2021).","journal-title":"Horm. Athens Greece"},{"issue":"1","key":"e_1_3_7_20_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ghir.2014.12.003","article-title":"Acromegaly and aging: a comparative cross-sectional study","volume":"25","author":"Hatipoglu E","year":"2015","unstructured":"Hatipoglu E, Yuruyen M, Keskin E Acromegaly and aging: a comparative cross-sectional study. Growth Horm. IGF Res. 25(1), 47\u201352 (2015).","journal-title":"Growth Horm. IGF Res."},{"issue":"1","key":"e_1_3_7_21_2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/13696998.2021.1898968","article-title":"Burden of acromegaly in the United States: increased health services utilization, location of care, and costs of care","volume":"24","author":"Ribeiro-Oliveira A","year":"2021","unstructured":"Ribeiro-Oliveira A, Brook RA, Munoz KA Burden of acromegaly in the United States: increased health services utilization, location of care, and costs of care. J. Med. Econ. 24(1), 432\u2013439 (2021).","journal-title":"J. Med. Econ."},{"issue":"12","key":"e_1_3_7_22_2","first-page":"1106","article-title":"Clinical and economic burden of commercially insured patients with acromegaly in the United States: a retrospective analysis","volume":"21","author":"Placzek H","year":"2015","unstructured":"Placzek H, Xu Y, Mu Y, Begelman SM, Fisher M. Clinical and economic burden of commercially insured patients with acromegaly in the United States: a retrospective analysis. J. Manag. Care Spec. Pharm. 21(12), 1106\u20131112 (2015).","journal-title":"J. Manag. Care Spec. Pharm."},{"issue":"10","key":"e_1_3_7_23_2","doi-asserted-by":"crossref","first-page":"bvad104","DOI":"10.1210\/jendso\/bvad104","article-title":"Treatment patterns, adherence, persistence, and health care resource utilization in acromegaly: a real-world analysis","volume":"7","author":"Fleseriu M","year":"2023","unstructured":"Fleseriu M, Barkan A, Brue T Treatment patterns, adherence, persistence, and health care resource utilization in acromegaly: a real-world analysis. J. Endocr. Soc. 7(10), bvad104 (2023).","journal-title":"J. Endocr. Soc."},{"issue":"10","key":"e_1_3_7_24_2","doi-asserted-by":"crossref","first-page":"e2236149","DOI":"10.1001\/jamanetworkopen.2022.36149","article-title":"Participation of older adults in clinical trials for new drug applications and biologics license applications from 2010 through 2019","volume":"5","author":"Lau SWJ","year":"2022","unstructured":"Lau SWJ, Huang Y, Hsieh J Participation of older adults in clinical trials for new drug applications and biologics license applications from 2010 through 2019. JAMA Netw. Open 5(10), e2236149 (2022).","journal-title":"JAMA Netw. Open"},{"issue":"10","key":"e_1_3_7_25_2","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1111\/bcp.14539","article-title":"Underrepresentation of the elderly in clinical trials, time for action","volume":"86","author":"Marum RJ","year":"2020","unstructured":"Marum RJ. Underrepresentation of the elderly in clinical trials, time for action. Br. J. Clin. Pharmacol. 86(10), 2014\u20132016 (2020).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"e_1_3_7_26_2","volume-title":"MarketScan Research Databases for life sciences research","author":"Merative","year":"2022","unstructured":"Merative. MarketScan Research Databases for life sciences research. Merative, MI, USA (2022)."},{"issue":"1","key":"e_1_3_7_27_2","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.2105\/AJPH.2009.162982","article-title":"Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change","volume":"100","author":"Herrera AP","year":"2010","unstructured":"Herrera AP, Snipes SA, King DW, Torres-Vigil I, Goldberg DS, Weinberg AD. Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change. Am. J. Public Health 100(Suppl. 1), S105\u2013S112 (2010).","journal-title":"Am. J. Public Health"},{"key":"e_1_3_7_28_2","doi-asserted-by":"crossref","first-page":"984877","DOI":"10.3389\/fendo.2022.984877","article-title":"Factors associated with therapeutic response in acromegaly diagnosed in the elderly in Spain","volume":"13","author":"Biagetti B","year":"2022","unstructured":"Biagetti B, Iglesias P, Villar-Taibo R Factors associated with therapeutic response in acromegaly diagnosed in the elderly in Spain. Front. Endocrinol. 13, 984877 (2022).","journal-title":"Front. Endocrinol."},{"issue":"3","key":"e_1_3_7_29_2","first-page":"377","article-title":"Acromegaly: pathophysiological considerations and treatment options including the evolving role of oral somatostatin analogs","volume":"30","author":"Daniel CP","year":"2023","unstructured":"Daniel CP, Wagner MJ, Borne GE Acromegaly: pathophysiological considerations and treatment options including the evolving role of oral somatostatin analogs. Pathophysiol. Off. J. Int. Soc. Pathophysiol. 30(3), 377\u2013388 (2023).","journal-title":"Pathophysiol. Off. J. Int. Soc. Pathophysiol."},{"key":"e_1_3_7_30_2","unstructured":"US Centers for Medicare and Medicaid Services. What's Medicare drug coverage (Part D)? (2025). Available at: https:\/\/www.medicare.gov\/health-drug-plans\/part-d"},{"key":"e_1_3_7_31_2","unstructured":"U.S. Bureau of Labor Statistics Division of Consumer Prices and Price Indexes. Consumer Price Index (2021). Available at: https:\/\/www.bls.gov\/cpi\/"},{"key":"e_1_3_7_32_2","doi-asserted-by":"crossref","first-page":"E76","DOI":"10.5888\/pcd14.160613","article-title":"Differences between younger and older US adults with multiple chronic conditions","volume":"14","author":"Adams ML","year":"2017","unstructured":"Adams ML. Differences between younger and older US adults with multiple chronic conditions. Prev. Chronic. Dis. 14, E76 (2017).","journal-title":"Prev. Chronic. Dis."},{"key":"e_1_3_7_33_2","article-title":"Treatments, complications, and healthcare utilization associated with acromegaly: a study in two large United States databases","author":"Broder MS","year":"2013","unstructured":"Broder MS, Neary MP, Chang E, Cherepanov D, Katznelson L. Treatments, complications, and healthcare utilization associated with acromegaly: a study in two large United States databases. Pituitary (2013).","journal-title":"Pituitary"},{"issue":"3","key":"e_1_3_7_34_2","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s11102-012-0432-6","article-title":"Real-world comorbidities and treatment patterns of patients with acromegaly in two large US health plan databases","volume":"16","author":"Burton T","year":"2013","unstructured":"Burton T, Le Nestour E, Bancroft T, Neary M. Real-world comorbidities and treatment patterns of patients with acromegaly in two large US health plan databases. Pituitary 16(3), 354\u2013362 (2013).","journal-title":"Pituitary"},{"issue":"2","key":"e_1_3_7_35_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11102-025-01503-6","article-title":"Long-term clinical outcome of 103 patients with acromegaly after pituitary surgery","volume":"28","author":"Pennlund A","year":"2025","unstructured":"Pennlund A, Esposito D, Bontell TO Long-term clinical outcome of 103 patients with acromegaly after pituitary surgery. Pituitary 28(2), 33 (2025).","journal-title":"Pituitary"},{"issue":"1","key":"e_1_3_7_36_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11102-012-0460-2","article-title":"Lanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry","volume":"17","author":"Salvatori R","year":"2014","unstructured":"Salvatori R, Woodmansee WW, Molitch M, Gordon MB, Lomax KG. Lanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry. Pituitary 17(1), 13\u201321 (2014).","journal-title":"Pituitary"},{"key":"e_1_3_7_37_2","doi-asserted-by":"crossref","first-page":"386401","DOI":"10.1155\/2012\/386401","article-title":"Surgery and radiosurgery for acromegaly: a review of indications, operative techniques, outcomes, and complications","volume":"2012","author":"Marquez Y","year":"2012","unstructured":"Marquez Y, Tuchman A, Zada G. Surgery and radiosurgery for acromegaly: a review of indications, operative techniques, outcomes, and complications. Int. J. Endocrinol. 2012, 386401 (2012).","journal-title":"Int. J. Endocrinol."},{"issue":"3","key":"e_1_3_7_38_2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.surg.2021.02.005","article-title":"High-risk surgery among older adults: not-quite shared decision-making","volume":"170","author":"De Roo AC","year":"2021","unstructured":"De Roo AC, Vitous CA, Rivard SJ High-risk surgery among older adults: not-quite shared decision-making. Surgery 170(3), 756\u2013763 (2021).","journal-title":"Surgery"},{"key":"e_1_3_7_39_2","doi-asserted-by":"crossref","DOI":"10.20452\/pamw.16232","article-title":"Gender and age differences among patients with acromegaly","author":"Bogus\u0142awska A","year":"2022","unstructured":"Bogus\u0142awska A, Gilis-Januszewska A, Godlewska M, Nowak A, Starzyk J, Hubalewska-Dydejczyk A. Gender and age differences among patients with acromegaly. Pol. Arch. Intern. Med. (2022).","journal-title":"Pol. Arch. Intern. Med."},{"issue":"11","key":"e_1_3_7_40_2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrendo.2010.170","article-title":"Surgery: risks of pituitary surgery in the elderly","volume":"6","author":"Freda PU","year":"2010","unstructured":"Freda PU, Bruce JN. Surgery: risks of pituitary surgery in the elderly. Nat. Rev. Endocrinol. 6(11), 606\u2013608 (2010).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"e_1_3_7_41_2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1227\/00006123-199504000-00006","article-title":"Pituitary surgery in elderly patients with acromegaly","volume":"36","author":"Puchner MJA","year":"1995","unstructured":"Puchner MJA, Knappe UJ, L\u00fcdecke DK. Pituitary surgery in elderly patients with acromegaly. Neurosurgery 36(4), 677\u2013684 (1995).","journal-title":"Neurosurgery"},{"issue":"3","key":"e_1_3_7_42_2","doi-asserted-by":"crossref","first-page":"A64","DOI":"10.1016\/j.jval.2015.03.375","article-title":"Barriers to treatment adherence associated with acromegaly in the United States: provider's perspective","volume":"18","author":"Liu S","year":"2015","unstructured":"Liu S, Xu Y, Begelman SM, Shi L. Barriers to treatment adherence associated with acromegaly in the United States: provider's perspective. Value Health 18(3), A64 (2015).","journal-title":"Value Health"},{"issue":"9","key":"e_1_3_7_43_2","first-page":"e28722","article-title":"A comprehensive review of four clinical practice guidelines of acromegaly","volume":"14","author":"Ogedegbe OJ","year":"2022","unstructured":"Ogedegbe OJ, Cheema AY, Khan MA A comprehensive review of four clinical practice guidelines of acromegaly. Cureus 14(9), e28722 (2022).","journal-title":"Cureus"},{"issue":"10","key":"e_1_3_7_44_2","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.eprac.2021.04.412","article-title":"Health benefit costs and absenteeism among employed patients with acromegaly","volume":"27","author":"Yuen KCJ","year":"2021","unstructured":"Yuen KCJ, Munoz KA, Brook RA Health benefit costs and absenteeism among employed patients with acromegaly. Endocr. Pract. 27(10), 1034\u20131039 (2021).","journal-title":"Endocr. Pract."},{"issue":"3","key":"e_1_3_7_45_2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40801-015-0039-0","article-title":"Treatment patterns and economic burden in patients treated for acromegaly in the USA","volume":"2","author":"Chuang C-C","year":"2015","unstructured":"Chuang C-C, Bhurke S, Chen S-Y, Dinet J, Brulais S, Gabriel S. Treatment patterns and economic burden in patients treated for acromegaly in the USA. Drugs \u2013 Real World Outcomes 2(3), 299\u2013309 (2015).","journal-title":"Drugs \u2013 Real World Outcomes"},{"key":"e_1_3_7_46_2","article-title":"Strengths and limits of claims and EHR-based data sources","author":"Sentinel Community Building and Outreach Center (CBOC)","unstructured":"Sentinel Community Building and Outreach Center (CBOC). Strengths and limits of claims and EHR-based data sources. Sentinel Initiative.","journal-title":"Sentinel Initiative."},{"issue":"1","key":"e_1_3_7_47_2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1460458213476506","article-title":"The challenges of linking health insurer claims with electronic medical records","volume":"20","author":"West SL","year":"2014","unstructured":"West SL, Johnson W, Visscher W, Kluckman M, Qin Y, Larsen A. The challenges of linking health insurer claims with electronic medical records. Health Informatics J. 20(1), 22\u201334 (2014).","journal-title":"Health Informatics J."},{"key":"e_1_3_7_48_2","article-title":"Strengths and limitations of real-world data from electronic health records and claims, and the value of combining data from these sources to inform research","author":"Verana Health","year":"2025","unstructured":"Verana Health. Strengths and limitations of real-world data from electronic health records and claims, and the value of combining data from these sources to inform research. Verana Health (2025).","journal-title":"Verana Health"},{"key":"e_1_3_7_49_2","unstructured":"NashBio. Claims Data vs EHRs: Distinct but United in Real-World Research (2023). Available at: https:\/\/nashbio.com\/blog\/ehr\/claims-data-vs-ehrs\/"},{"issue":"1","key":"e_1_3_7_50_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-022-08882-7","article-title":"Real world challenges in integrating electronic medical record and administrative health data for regional quality improvement in diabetes: a retrospective cross-sectional analysis","volume":"23","author":"Swaleh R","year":"2023","unstructured":"Swaleh R, McGuckin T, Campbell-Scherer D, Setchell B, Senior P, Yeung RO. Real world challenges in integrating electronic medical record and administrative health data for regional quality improvement in diabetes: a retrospective cross-sectional analysis. BMC Health Serv. Res. 23(1), 1 (2023).","journal-title":"BMC Health Serv. Res."},{"key":"e_1_3_7_51_2","volume-title":"Linking healthCAre claims and electronic health records (EHR) for patient management \u2013 Diabetes Case Study","author":"LaBrec PA","year":"2014","unstructured":"LaBrec PA. Linking healthCAre claims and electronic health records (EHR) for patient management \u2013 Diabetes Case Study. 3M Health Information Solutions, CA, USA (2014)."},{"issue":"1","key":"e_1_3_7_52_2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s43856-025-00769-y","article-title":"Data linkage multiplies research insights across diverse healthcare sectors","volume":"5","author":"Eisinger-Mathason TSK","year":"2025","unstructured":"Eisinger-Mathason TSK, Leshin J, Lahoti V, Fridsma DB, Mucaj V, Kho AN. Data linkage multiplies research insights across diverse healthcare sectors. Commun. Med. 5(1), 58 (2025).","journal-title":"Commun. Med."},{"key":"e_1_3_7_53_2","volume-title":"Tools and Technologies for Registry Interoperability, Registries for Evaluating Patient Outcomes: A User's Guide (Volume Addendum 2 (3rd Edition))","author":"Ehrenstein V","year":"2019","unstructured":"Ehrenstein V, Kharrazi H, Lehmann H, Overby Taylor C. Obtaining data from electronic health records. In: Tools and Technologies for Registry Interoperability, Registries for Evaluating Patient Outcomes: A User's Guide (Volume Addendum 2 (3rd Edition)). Agency for Healthcare Research and Quality, MD, USA (2019)."}],"container-title":["Journal of Comparative Effectiveness Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/becarispublishing.com\/doi\/pdf\/10.57264\/cer-2025-0076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T08:53:37Z","timestamp":1756457617000},"score":1,"resource":{"primary":{"URL":"https:\/\/becarispublishing.com\/doi\/10.57264\/cer-2025-0076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.57264\/cer-2025-0076"],"URL":"https:\/\/doi.org\/10.57264\/cer-2025-0076","relation":{},"ISSN":["2042-6305","2042-6313"],"issn-type":[{"value":"2042-6305","type":"print"},{"value":"2042-6313","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"article-number":"e250076"}}